Do not confuse a possible interaction with a therapeutic effect
A review of drug–nutrient interactions reports a case of substantially increased INR in a person taking warfarin and astaxanthin. A case report can flag a possible safety signal but cannot establish how often it occurs, prove causation by itself or define an effective blood-thinning dose. [1]
General safety assessments answer a different question
EFSA assessed specified astaxanthin exposures for food-supplement safety in adults. That assessment does not certify every combination with anticoagulants or every patient with a bleeding disorder. Product form, amount, other ingredients and the person’s treatment remain relevant. [2]
Make changes through the prescribing team
Imagine a warfarin user wants to add an antioxidant capsule. Tell the anticoagulation clinician before starting or stopping it so monitoring can be considered. Do not reduce a prescribed blood thinner because of a supplement claim. Unusual bleeding or extensive unexplained bruising warrants prompt medical attention, rather than experimentation with servings. [1][3]
| Question | Useful check |
|---|---|
| What is the target? | A defined symptom or clinical result |
| What is the exposure? | Full formula and medicines |
| What supports the claim? | Evidence matching the person and outcome |
Sources for this article
- Potential Drug–Nutrient Interactions of 45 Vitamins, Minerals, Trace Elements, and Associated Dietary Compounds with Acetylsalicylic Acid and Warfarin—A Review of the Literature - PMC
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Safety of astaxanthin for its use as a novel food in food supplements - PMC
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Dietary Supplements: What You Need to Know - Consumer
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.